Liraglutide
- •what is Liraglutide
- •Liraglutide vs Semaglutide
- •Saxenda Victoza
- •Liraglutide weight loss research
- •Liraglutide GLP-1
- Liraglutide(Saxenda, Victoza)· Weight Loss & Metabolism
- Liraglutide is the once-a-day predecessor to Semaglutide. Same family, same general idea — slow stomach emptying, increase satiety, support insulin response — just shorter duration.
What is it?
Liraglutide is a GLP-1 receptor agonist with a fatty acid side chain that extends its half-life to roughly 13 hours, allowing once-daily dosing. It was the first long-acting GLP-1 approved for weight management (Saxenda) and type 2 diabetes (Victoza).
In plain English
Liraglutide is the once-a-day predecessor to Semaglutide. Same family, same general idea — slow stomach emptying, increase satiety, support insulin response — just shorter duration.
How it works
Activates GLP-1 receptors in the pancreas, gut, and brain to enhance glucose-dependent insulin secretion, slow gastric emptying, and reduce appetite.
What researchers study
- •Type 2 diabetes glucose control
- •Obesity and weight management
- •Cardiovascular outcomes research
- •Comparison with Semaglutide and Tirzepatide
- •Appetite and reward pathway research
What the internet talks about
Often described as the 'gateway GLP-1' before the Semaglutide/Tirzepatide wave. Threads compare daily dosing convenience against the appetite suppression strength of weekly options.
Bro-science translation
“The daily-dose original of the GLP-1 family.”
Commonly compared to
Common stack discussions
Compared with Semaglutide and Tirzepatide. Sometimes discussed alongside Cagrilintide or metformin in metabolic stacks.
Related peptides
Related categories
Frequently asked questions
Quick summary
Liraglutide is a daily GLP-1 receptor agonist studied for glucose control and weight management — the predecessor to weekly GLP-1s like Semaglutide.